Group 1: Company Changes and Management - In 2025, the company optimized offline sales channels and improved the management team by hiring high-end talent, enhancing overall management capabilities [1] - The management team now effectively complements the existing team, leading to improved performance [1] Group 2: Product Structure - The company's product structure is divided into two main categories: medical devices and cosmetics, with various forms including dressings, masks, lotions, creams, serums, and sprays [1] - The products cover a wide range of functions such as whitening, acne treatment, anti-wrinkle, and repair, showcasing a rich variety of formulations and comprehensive efficacy [1] Group 3: New Product Plans - The company has plans for new products in both medical devices and cosmetics for 2026, with a focus on various forms including dressings, masks, and serums [1] - The actual launch situation will be confirmed later, and stakeholders are encouraged to stay updated [1] Group 4: Sales Channels and Market Strategy - Both online and offline channels are considered main battlegrounds for the company, with significant efforts made in offline channel optimization in 2025 [2] - The company is well-prepared for offline business in 2026, aiming for improved performance in this area [2] Group 5: Product Launch and Certification - The company had a successful product launch in 2025 and is optimistic about new products in 2026, with plans for effective promotion and marketing [2] - The timeline for certification of three types of injection products depends on regulatory approval, and updates will be disclosed accordingly [2] Group 6: Shareholder Information - The chairman currently has no plans to reduce shareholding, and any future changes will be disclosed in compliance with regulatory requirements [2] - The dividend plan for this year has not yet been determined, with an announcement expected on April 23, 2026 [2]
敷尔佳(301371) - 2026年3月11日投资者关系活动记录表（二）